Breaking News

OmniReliant Holdings Acquires Topical Pharmaceutical Patent

January 25, 2008

OmniReliant Holdings, Inc. of Tampa, FL has formally acquired the rights to a unique patented topical pharmaceutical product.

OmniReliant Holdings, Inc. of Tampa, FL has formally acquired the rights to a unique patented topical pharmaceutical product capable of delivering salicylic acid in a non-stick clear solid composition to treat acne. The company will use the patented product to compliment its patent pending warming foam acne treatment product.

According to the company, its lead scientists William Bess and Leonard Mackles, who conceived the product, have agreed to sell the patent and collaborate with OmniReliant Holdings, Inc. to bring the formula to the highly competitive acne treatment market.


blog comments powered by Disqus